- Home
- TORO vs CCEL Comparison
TORO vs CCEL Comparison
Compare TORO & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TORO
- CCEL
- Stock Information
- Founded
- TORO 2022
- CCEL 1989
- Country
- TORO Cyprus
- CCEL United States
- Employees
- TORO N/A
- CCEL N/A
- Industry
- TORO Marine Transportation
- CCEL Managed Health Care
- Sector
- TORO Consumer Discretionary
- CCEL Health Care
- Exchange
- TORO Nasdaq
- CCEL Nasdaq
- Market Cap
- TORO 55.1M
- CCEL 56.8M
- IPO Year
- TORO N/A
- CCEL 1997
- Fundamental
- Price
- TORO $2.54
- CCEL $7.17
- Analyst Decision
- TORO
- CCEL Strong Buy
- Analyst Count
- TORO 0
- CCEL 1
- Target Price
- TORO N/A
- CCEL $8.50
- AVG Volume (30 Days)
- TORO 22.9K
- CCEL 18.5K
- Earning Date
- TORO 03-18-2025
- CCEL 04-14-2025
- Dividend Yield
- TORO N/A
- CCEL 3.49%
- EPS Growth
- TORO N/A
- CCEL N/A
- EPS
- TORO 0.99
- CCEL 0.05
- Revenue
- TORO $80,626,531.00
- CCEL $31,986,106.00
- Revenue This Year
- TORO N/A
- CCEL $2.82
- Revenue Next Year
- TORO N/A
- CCEL $0.99
- P/E Ratio
- TORO $0.90
- CCEL $145.04
- Revenue Growth
- TORO 52.03
- CCEL 2.05
- 52 Week Low
- TORO $2.25
- CCEL $5.35
- 52 Week High
- TORO $6.06
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- TORO 36.37
- CCEL 45.20
- Support Level
- TORO $2.46
- CCEL $6.31
- Resistance Level
- TORO $2.62
- CCEL $7.31
- Average True Range (ATR)
- TORO 0.10
- CCEL 0.58
- MACD
- TORO -0.01
- CCEL -0.08
- Stochastic Oscillator
- TORO 27.59
- CCEL 45.88
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.